Orion’s pharmaceutical innovations are created within its R&D organisation. The organisation employs top professionals in the field of drug molecule development and optimisation.
There are around 500 professionals working in R&D. Orion has offices in Espoo, Turku and Kuopio in Finland, and in Nottingham in England and Mumbai in India.
In its own R&D, Orion focuses on early-phase drug development. Orion has launched several proprietary products onto the market in various therapy areas.
In the initial and final stages of research projects Orion works together with skilled partners, such as universities and other pharmaceutical companies.
The partnerships allow Orion to work on a large number of research projects simultaneously while focusing on its own core competence. Successful research also benefits our partners.
"I’m inspired by our input in research and product development. For example, great opportunities may be presented by biologic drugs, which are being developed extensively around the world", says Christer Nordstedt.
Like in all other operations, our aim is to work in accordance with the requirements, standards and ethical codes of our industry in our pharmaceutical research and development activities too. Our R&D Policy highlights how we make sure that our practices are on an ethically sustainable basis.